Page last updated: 2024-08-24

imiquimod and Carcinoma, Squamous Cell of Head and Neck

imiquimod has been researched along with Carcinoma, Squamous Cell of Head and Neck in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
McLaughlin, PJ; Stucki, JK; Zagon, IS1

Other Studies

1 other study(ies) available for imiquimod and Carcinoma, Squamous Cell of Head and Neck

ArticleYear
Modulation of the opioid growth factor ([Met(5)]-enkephalin)-opioid growth factor receptor axis: novel therapies for squamous cell carcinoma of the head and neck.
    Head & neck, 2012, Volume: 34, Issue:4

    Topics: Aminoquinolines; Analysis of Variance; Animals; Carcinoma, Squamous Cell; Disease Models, Animal; DNA; Dose-Response Relationship, Drug; Drug Administration Schedule; Head and Neck Neoplasms; Humans; Imiquimod; Injections, Intraperitoneal; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Receptors, Opioid; Reference Values; Squamous Cell Carcinoma of Head and Neck; Transplantation, Heterologous; Treatment Outcome; Tumor Burden; Up-Regulation

2012